Ganciclovir by Infusion and by Mouth in Treating Patients With Cytomegalovirus After Donor Bone Marrow Transplant

NCT00530218 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

61

Enrollment

OTHER

Sponsor class

Conditions

Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
Leukemia
Lymphoma
Multiple Myeloma
MDS
Myelodysplastic/Myeloproliferative Diseases

Interventions

DRUG: Ganciclovir

Sponsor

City of Hope Medical Center

Collaborators

[object Object]